Cargando…

Clinical implication of initial intravenous diuretic dose for acute decompensated heart failure

Although intravenous diuretics is a cornerstone of acute heart failure treatment (AHF), its optimal initial dose is unclear. This is a post-hoc analysis of the REALITY-AHF, a prospective multicentre observational registry of AHF. The initial intravenous diuretic dose used in each patient was categor...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yoshioka, Kenji, Maeda, Daichi, Okumura, Takahiro, Kida, Keisuke, Oishi, Shogo, Akiyama, Eiichi, Suzuki, Satoshi, Yamamoto, Masayoshi, Mizukami, Akira, Kuroda, Shunsuke, Kagiyama, Nobuyuki, Yamaguchi, Tetsuo, Sasano, Tetsuo, Matsumura, Akihiko, Kitai, Takeshi, Matsue, Yuya
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8825846/ https://www.ncbi.nlm.nih.gov/pubmed/35136147 http://dx.doi.org/10.1038/s41598-022-06032-x

Ejemplares similares

Impact of brain natriuretic peptide reduction on the worsening renal function in patients with acute heart failure
por: Yoshioka, Kenji, et al.
Publicado: (2020)

Effect of carperitide on the 1 year prognosis of patients with acute decompensated heart failure
por: Nogi, Kazutaka, et al.
Publicado: (2022)

Sinus node dysfunction characterized by reduction only in maximum heart rate during exercise after superior vena cava isolation in atrial fibrillation catheter ablation—A potential complication
por: Hayashi, Tatsuya, et al.
Publicado: (2020)

Larissa Heart Failure Risk Score and Mode of Death in Acute Heart Failure: Insights from REALITY-AHF
por: Xanthopoulos, Andrew, et al.
Publicado: (2023)

Predictive value of noninducibility after catheter ablation for paroxysmal and persistent atrial fibrillation
por: Tachibana, Shinichi, et al.
Publicado: (2020)

Impact of early treatment with intravenous vasodilators and blood pressure reduction in acute heart failure
por: Kitai, Takeshi, et al.
Publicado: (2018)

Association between class of foundational medication for heart failure and prognosis in heart failure with reduced/mildly reduced ejection fraction
por: Ito, Miyuki, et al.
Publicado: (2022)

The time-to-treatment concept in acute heart failure: Lessons and implications from REALITY-AHF
por: Kagiyama, Nobuyuki, et al.
Publicado: (2018)

Early treatment with tolvaptan improves diuretic response in acute heart failure with renal dysfunction
por: Matsue, Yuya, et al.
Publicado: (2017)

Tolvaptan Add-on Therapy to Overcome Loop Diuretic Resistance in Acute Heart Failure With Renal Dysfunction (DR-AHF): Design and Rationale
por: Minh, Nhat Giang, et al.
Publicado: (2022)

Impact of body mass index on the outcome of Japanese patients with cardiovascular diseases and/or risk factors hospitalized with COVID-19 infection
por: Saito, Takafumi, et al.
Publicado: (2022)

The Prognostic Value of B‐Type Natriuretic Peptide in Patients With Cardiac Sarcoidosis Without Heart Failure: Insights From ILLUMINATE‐CS
por: Miyakuni, Shota, et al.
Publicado: (2022)

Risk factors for venous bleeding complication at the femoral puncture site after catheter ablation of atrial fibrillation
por: Arai, Hirofumi, et al.
Publicado: (2020)

Outcomes of deep sedation for catheter ablation of paroxysmal supraventricular tachycardia, with adaptive servo ventilation
por: Hayashi, Tatsuya, et al.
Publicado: (2020)

Histological examination of the right atrial appendage after failed catheter ablation for focal atrial tachycardia complicated by cardiogenic shock in a post-partum patient
por: Mizukami, Akira, et al.
Publicado: (2016)

Verapamil-sensitive ventricular tachycardia demonstrating multiform QRS morphology in a patient with ischemic cardiomyopathy
por: Kuroda, Shunsuke, et al.
Publicado: (2019)

Effect of diuretic infusion clinic in preventing hospitalization for patients with decompensating heart failure
por: Alghalayini, Kamal Waheeb
Publicado: (2020)

Assessment of thromboembolism risk in COVID-19 patients with cardiovascular disease risk factors: Analysis of a Japanese Nationwide Registry()
por: Shibahashi, Eiji, et al.
Publicado: (2022)

Inferior Vena Cava Thrombus due to Left Inferior Vena Cava and Ulcerative Colitis
por: Arai, Hirofumi, et al.
Publicado: (2018)

Inflammatory and Hypercoagulable Biomarkers and Clinical Outcomes in COVID-19 Patients
por: Kitakata, Hiroki, et al.
Publicado: (2021)

High-Sensitivity Troponin T: A Biomarker for Diuretic Response in Decompensated Heart Failure Patients
por: Ferreira, João Pedro, et al.
Publicado: (2014)

Triple Diuretics and Aquaretic Strategy for Acute Decompensated Heart Failure due to Volume Overload
por: Jermyn, Rita, et al.
Publicado: (2013)

Impact of chronic kidney disease on the diuretic response of tolvaptan in acute decompensated heart failure
por: Ikeda, Shuntaro, et al.
Publicado: (2017)

Trial of Oral Diuretics Prior to Discharge Is Not Associated With Improved Outcomes in Decompensated Heart Failure
por: Mohammad, Adeba, et al.
Publicado: (2021)

Effect of the COVID-19 Pandemic on Acute Respiratory Care of Hypoxemic Patients With Acute Heart Failure in Japan　― A Cross-Sectional Study ―
por: Matsue, Yuya, et al.
Publicado: (2020)

Prognostic Implication of the Resolution of Myocardial FDG Uptake in Patients With Cardiac Sarcoidosis
por: Okabe, Toshitaka, et al.
Publicado: (2023)

Renoprotective Benefit of Tolvaptan in Acute Decompensated Heart Failure Patients With Loop Diuretic-Resistant Status
por: Yamamoto, Tomohiko, et al.
Publicado: (2019)

Great debate: in patients with decompensated heart failure, acetazolamide in addition to loop diuretics is the first choice
por: Mullens, Wilfried, et al.
Publicado: (2023)

Kaplan–Meier survival analysis and Cox regression analyses regarding right ventricular septal pacing: Data from Japanese pacemaker cohort
por: Mizukami, Akira, et al.
Publicado: (2016)

Validation of telemedicine-based self-assessment of vital signs for patients with COVID-19: A pilot study
por: Kagiyama, Nobuyuki, et al.
Publicado: (2021)

Point-of-Care, Ultraportable Echocardiography Predicts Diuretic Response in Patients Admitted with Acute Decompensated Heart Failure
por: Krishnan, Dena K., et al.
Publicado: (2016)

Sex Differences in Clinical Outcomes Among Patients With COVID-19 and Cardiovascular Disease　― Insights From the CLAVIS-COVID Registry ―
por: Matsumoto, Shingo, et al.
Publicado: (2022)

Diuretic response in patients with acute decompensated heart failure: characteristics and clinical outcome—an analysis from RELAX-AHF
por: Voors, Adriaan A, et al.
Publicado: (2014)

Six-Month Predictive Value of Diuretic Resistance Formulas in Discharged Heart Failure Patients after an Acute Decompensation
por: Feola, Mauro, et al.
Publicado: (2020)

Sodium glucose cotransporter 2 inhibitors as diuretic adjuvants in acute decompensated heart failure: a case series
por: Griffin, Matthew, et al.
Publicado: (2020)

Patients with high-dose diuretics should get ultrafiltration in the management of decompensated heart failure: a meta-analysis
por: Shi, Xiaofeng, et al.
Publicado: (2019)

The angle of the tines before the pull and hold test predicts engagement of the tines in Micra leadless pacemaker implantation
por: Mizukami, Akira, et al.
Publicado: (2022)

Neuroendocrine hormone status and diuretic response to atrial natriuretic peptide in patients with acute heart failure
por: Matsumoto, Shingo, et al.
Publicado: (2022)

The interaction between physical frailty and prognostic impact of heart failure medication in elderly patients
por: Abe, Takuro, et al.
Publicado: (2023)

Sarcopenic obesity is associated with impaired physical function and mortality in older patients with heart failure: insight from FRAGILE-HF
por: Saito, Hiroshi, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_43378fu9vj12867crr444sejb9